Cargando…

Autocrine Effects of Tumor-Derived Complement

We describe a role for the complement system in enhancing cancer growth. Cancer cells secrete complement proteins that stimulate tumor growth upon activation. Complement promotes tumor growth via a direct autocrine effect that is partially independent of tumor-infiltrating cytotoxic T cells. Activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Min Soon, Vasquez, Hernan G., Rupaimoole, Rajesha, Pradeep, Sunila, Wu, Sherry, Zand, Behrouz, Han, Hee-Dong, Rodriguez-Aguayo, Cristian, Bottsford-Miller, Justin, Huang, Jie, Miyake, Takahito, Choi, Hyun-Jin, Dalton, Heather J., Ivan, Cristina, Baggerly, Keith, Lopez-Berestein, Gabriel, Sood, Anil K., Afshar-Kharghan, Vahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084868/ https://www.ncbi.nlm.nih.gov/pubmed/24613353 http://dx.doi.org/10.1016/j.celrep.2014.02.014

Ejemplares similares

MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011)

Pan-cancer genomic analysis links 3’UTR DNA methylation with increased gene expression in T cells
por: McGuire, Michael H., et al.
Publicado: (2019)

ADH1B promotes mesothelial clearance and ovarian cancer infiltration
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2014)

Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis
por: Nagaraja, Archana S., et al.
Publicado: (2015)

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
por: Haemmerle, Monika, et al.
Publicado: (2017)

Targeting KRas-dependent tumor growth, circulating tumor cells and metastasis in vivo by clinically significant miR-193a-3p
por: Seviour, Elena G., et al.
Publicado: (2016)

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2016)

FABP4 as a key determinant of metastatic potential of ovarian cancer
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

Platelet activation leads to activation and propagation of the complement system
por: del Conde, Ian, et al.
Publicado: (2005)

Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers
por: Moss, Tyler J, et al.
Publicado: (2015)

Anticomplement therapy
por: Kulkarni, Prathit A, et al.
Publicado: (2008)

Platelets in pulmonary vascular physiology and pathology
por: Kroll, Michael H., et al.
Publicado: (2012)

Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective
por: Menter, David G., et al.
Publicado: (2022)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2
por: Rytelewski, Mateusz, et al.
Publicado: (2016)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells
por: Rupaimoole, Rajesha, et al.
Publicado: (2020)

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
por: Wu, Sherry Y., et al.
Publicado: (2016)

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
por: Mangala, Lingegowda S., et al.
Publicado: (2021)

Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
por: Hu, Qianghua, et al.
Publicado: (2016)

Platelets Increase the Expression of PD-L1 in Ovarian Cancer
por: Cho, Min Soon, et al.
Publicado: (2022)

Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
por: Nagaraja, Archana S., et al.
Publicado: (2021)

Role of Factor Xa Inhibitors in Cancer-Associated Thrombosis: Any New Data?
por: Zalpour, Ali, et al.
Publicado: (2011)

Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer
por: Saha, Biswajit, et al.
Publicado: (2021)

Immune cell profiling in cancer: molecular approaches to cell-specific identification
por: Lyons, Yasmin A., et al.
Publicado: (2017)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

Heparin-induced thrombocytopenia among patients of a comprehensive cancer center
por: Wu, Weixin, et al.
Publicado: (2014)

Macrophage TGF-β1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions
por: Moritz, Robert J., et al.
Publicado: (2016)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
por: George, Jasmine, et al.
Publicado: (2021)

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
por: Yang, Lifeng, et al.
Publicado: (2014)

A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
por: Masiero, Massimo, et al.
Publicado: (2013)

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer
por: Rabinowicz, Noa, et al.
Publicado: (2017)

The Provocative Roles of Platelets in Liver Disease and Cancer
por: Kanikarla Marie, Preeti, et al.
Publicado: (2021)

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
por: Wang, Enfeng, et al.
Publicado: (2011)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Calcium Dependent FAK/CREB/TNNC1 Signaling Mediates the Effect of Stromal MFAP5 on Ovarian Cancer Metastatic Potential
por: Leung, Cecilia S., et al.
Publicado: (2014)

Autocrine PDGF stimulation in malignancies
por: Heldin, Carl-Henrik
Publicado: (2012)

GPCRs in Autocrine and Paracrine Regulations
por: Tse, Lap Hang, et al.
Publicado: (2019)

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
por: Tseng, Jill H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4kl5399d0a7sm01bdgvoluinhf